At CES we see a lot of strange and weird gadgets but one that is nether strange nor weird but looks extremely useful that has caught our eye here at EFTM is the Noninvasive Glucometer Wristband from Quantum Operation, a Tokyo-based healthcare IoT startup. The new watch offers continuous monitoring of your blood glucose without having to provide a blood sample every time.
With an ever-increasing number of people afflicted with diabetes in the world each year the new non-invasive wristband could provide a welcome relief for many sufferers offering peace of mind as well and increased health and safety.
Quantum Operation’s world first non-invasive glucometer in the form of a wristband that is capable of non-stop blood glucose monitoring. Using the company’s patented spectrum sensing technology it can accurately measure glucose in a person’s bloodstream through the skin thus eliminating the need of daily needle use for diabetic patients. Along with this continuous monitoring the company will soon be adding the ability to monitor changes in pre- and post-meal blood glucose levels – something diabetics need to keep a close eye on as they monitor their disease.
“Although checking one’s blood glucose level both before and after a meal is important, that adds to patients’ already taxing daily routine of sticking a needle into their fingers or arms so many times a day. We are thrilled to be able to make this all pain-free and effortless for them,” Quantum Operation CEO Kazuma Kato said. “Diabetes affects 463 million people worldwide, causing 1.5 million deaths from it each year. We are thrilled to demonstrate at CES 2022 how our technology can revolutionize the patients’ daily disease management.”
The technology used in the wristband can also be used to measure other vital signs such as heart rate and oxygen saturation. This can enable healthcare providers to monitor a patient’s medical condition closely but remotely.
At this stage, the wristband is only in prototype form, and it is unknown just when a product will be ready for release to the public but when it does, we think that it could make a big splash in the healthcare wearable industry and, more importantly, improve the quality of life for diabetic patients.
EFTM’s coverage of CES 2022 is supported by Intel, Vodafone, LG, Samsung and Hisense.